Brought to you by 
Sonexa Therapeutics takes in $30mm through first round
05 Feb 2008
Executive Summary
Sonexa Therapeutics (neurodegenerative disorders) has grossed $30mm in its Series A financing led by Domain Associates, Scale Venture Partners, and Alta Partners, each of which contributes new company board members. AgeChem Venture Fund and MC Life Science Ventures also participated.
Deal Industry
- Biotechnology
- Pharmaceuticals
Deal Status
- Final
Deal Type
-
Financing
- Venture Financing
Already a Biomedtracker subscriber?
You have access to the full deal record through your subscription
Want to become a subscriber?
Subscribers get more deal details, updates, deal financials and deal products.
Questions?
Questions?
Please contact Sales at: (212) 520-2765 or email [email protected]
Related Companies
You must sign in to use this functionality
Authentication.SignIn.HeadSignInHeader
Sonexa Therapeutics takes in $30mm through first round
Email Deal
All set! This article has been sent to my@email.address.
All fields are required. For multiple recipients, separate email addresses with a semicolon.
DCD.EmailPopout.Notice